BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lamagni TL, Neal S, Keshishian C, Alhaddad N, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg Infect Dis 2008;14:202-9. [PMID: 18258111 DOI: 10.3201/eid1402.070888] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Klonoski JM, Hurtig HR, Juber BA, Schuneman MJ, Bickett TE, Svendsen JM, Burum B, Penfound TA, Sereda G, Dale JB, Chaussee MS, Huber VC. Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection. Vaccine 2014;32:5241-9. [PMID: 25077423 DOI: 10.1016/j.vaccine.2014.06.093] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
2 Siljander T, Lyytikäinen O, Vähäkuopus S, Snellman M, Jalava J, Vuopio J. Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland. Eur J Clin Microbiol Infect Dis 2010;29:1229-35. [PMID: 20563620 DOI: 10.1007/s10096-010-0989-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
3 Lee LH, Chalmers R, Muir T. Diagnosis, management and outcomes of necrotising soft tissue infection within a Plastic and Reconstructive Surgery unit. Scott Med J. 2014;59:56-61. [PMID: 24419229 DOI: 10.1177/0036933013518155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Javed B, Farooq F, Ibrahim M, Abbas HAB, Jawwad H, Zehra SS, Ahmad HM, Sarwer A, Malik K, Nawaz K. Antibacterial and antifungal activity of methanolic extracts of Salix alba L. against various disease causing pathogens. Braz J Biol 2021;83:e243332. [PMID: 34730611 DOI: 10.1590/1519-6984.243332] [Reference Citation Analysis]
5 Monneuse O, Tissot E, Gruner L, Michaillard Kaempf F, Allaouchiche B, Etienne J, Barth X. Diagnosis and treatment of spontaneous group A streptococcal peritonitis. Br J Surg 2010;97:104-8. [PMID: 20013929 DOI: 10.1002/bjs.6822] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
6 Bachert BA, Choi SJ, LaSala PR, Harper TI, McNitt DH, Boehm DT, Caswell CC, Ciborowski P, Keene DR, Flores AR, Musser JM, Squeglia F, Marasco D, Berisio R, Lukomski S. Unique Footprint in the scl1.3 Locus Affects Adhesion and Biofilm Formation of the Invasive M3-Type Group A Streptococcus. Front Cell Infect Microbiol 2016;6:90. [PMID: 27630827 DOI: 10.3389/fcimb.2016.00090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
7 Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis 2008;8:120. [PMID: 18801177 DOI: 10.1186/1471-2334-8-120] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 5.3] [Reference Citation Analysis]
8 Bruun T, Rath E, Madsen MB, Oppegaard O, Nekludov M, Arnell P, Karlsson Y, Babbar A, Bergey F, Itzek A, Hyldegaard O, Norrby-Teglund A, Skrede S; INFECT Study Group. Risk Factors and Predictors of Mortality in Streptococcal Necrotizing Soft-tissue Infections: A Multicenter Prospective Study. Clin Infect Dis 2021;72:293-300. [PMID: 31923305 DOI: 10.1093/cid/ciaa027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
9 Hope VD, Ncube F, Parry JV, Hickman M. Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England. Epidemiol Infect 2015;143:120-31. [PMID: 24568684 DOI: 10.1017/S0950268814000284] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
10 Close RM, McAuley JB. Disparate Effects of Invasive Group A Streptococcus on Native Americans. Emerg Infect Dis 2020;26:1971-7. [PMID: 32818411 DOI: 10.3201/eid2609.181169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tsoi SK, Smeesters PR, Frost HR, Licciardi P, Steer AC. Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus. J Immunol Res 2015;2015:167089. [PMID: 26101780 DOI: 10.1155/2015/167089] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
12 Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 2011;9:724-36. [PMID: 21921933 DOI: 10.1038/nrmicro2648] [Cited by in Crossref: 268] [Cited by in F6Publishing: 235] [Article Influence: 24.4] [Reference Citation Analysis]
13 Watts V, Balasegaram S, Brown CS, Mathew S, Mearkle R, Ready D, Saliba V, Lamagni T. Increased Risk for Invasive Group A Streptococcus Disease for Household Contacts of Scarlet Fever Cases, England, 2011-2016. Emerg Infect Dis 2019;25:529-37. [PMID: 30602121 DOI: 10.3201/eid2503.181518] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lamb LE, Sriskandan S, Tan LK. Bromine, bear-claw scratch fasciotomies, and the Eagle effect: management of group A streptococcal necrotising fasciitis and its association with trauma. Lancet Infect Dis 2015;15:109-21. [PMID: 25541175 DOI: 10.1016/S1473-3099(14)70922-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
15 Leroy S, Marc E, Bavoux F, Tréluyer JM, Gendrel D, Bréart G, Pons G, Chalumeau M. Hospitalization for severe bacterial infections in children after exposure to NSAIDs: a prospective adverse drug reaction reporting study. Clin Drug Investig 2010;30:179-85. [PMID: 20155990 DOI: 10.2165/11532890-000000000-00000] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
16 Whitehead BD, Smith HV, Nourse C. Invasive group A streptococcal disease in children in Queensland. Epidemiol Infect 2011;139:623-8. [DOI: 10.1017/s0950268810001378] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
17 Hervás D, Hervás-masip J, Ferrés L, Ramírez A, Pérez JL, Hervás JA. Effects of meteorologic factors and schooling on the seasonality of group A streptococcal pharyngitis. Int J Biometeorol 2016;60:763-9. [DOI: 10.1007/s00484-015-1072-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
18 Lu J, Francis J, Doster RS, Haley KP, Craft KM, Moore RE, Chambers SA, Aronoff DM, Osteen K, Damo SM, Manning S, Townsend SD, Gaddy JA. Lactoferrin: A Critical Mediator of Both Host Immune Response and Antimicrobial Activity in Response to Streptococcal Infections. ACS Infect Dis 2020;6:1615-23. [PMID: 32329605 DOI: 10.1021/acsinfecdis.0c00050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
19 Oliver J, Wilmot M, Strachan J, St George S, Lane CR, Ballard SA, Sait M, Gibney K, Howden BP, Williamson DA. Recent trends in invasive group A Streptococcus disease in Victoria. Commun Dis Intell 2019;43. [DOI: 10.33321/cdi.2019.43.8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
20 Vayvada H, Demirdover C, Menderes A, Karaca C. Necrotising fasciitis in the central part of the body: diagnosis, management and review of the literature. Int Wound J 2013;10:466-72. [PMID: 22694053 DOI: 10.1111/j.1742-481X.2012.01006.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
21 Krzyściak W, Pluskwa KK, Jurczak A, Kościelniak D. The pathogenicity of the Streptococcus genus. Eur J Clin Microbiol Infect Dis 2013;32:1361-76. [PMID: 24141975 DOI: 10.1007/s10096-013-1914-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
22 Lavender TW, McCarron B. Acute infections in intravenous drug users. Clin Med (Lond) 2013;13:511-3. [PMID: 24115713 DOI: 10.7861/clinmedicine.13-5-511] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
23 Faisantieu N, Kowalski V, Soulié B. [Benefits and risks of ibuprofen in children with fever: Overview of the literature with a view to producing a written information tool for parents]. Therapie 2020;75:553-67. [PMID: 32571587 DOI: 10.1016/j.therap.2020.04.005] [Reference Citation Analysis]
24 Okamoto S, Nagase S. Pathogenic mechanisms of invasive group A Streptococcus infections by influenza virus-group A Streptococcus superinfection: Invasive GAS infection by superinfection. Microbiol Immunol 2018;62:141-9. [DOI: 10.1111/1348-0421.12577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ibáñez Barceló M, Pomar Solchaga V, Castañeda S. Infecciones de partes blandas. Medicina Clínica 2009;133:139-46. [DOI: 10.1016/j.medcli.2008.10.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen Safety at the Golden Anniversary: Are all NSAIDs the Same? A Narrative Review. Adv Ther 2020;37:61-82. [PMID: 31705437 DOI: 10.1007/s12325-019-01144-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
27 Turner CE, Dryden M, Holden MT, Davies FJ, Lawrenson RA, Farzaneh L, Bentley SD, Efstratiou A, Sriskandan S. Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes. J Clin Microbiol 2013;51:2089-95. [PMID: 23616448 DOI: 10.1128/JCM.00679-13] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
28 Banigo A, Moinie A, Bleach N, Chand M, Chalker V, Lamagni T. Have reducing tonsillectomy rates in England led to increasing incidence of invasive Group A Streptococcus infections in children? Clin Otolaryngol 2018;43:912-9. [DOI: 10.1111/coa.13095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Safar A, Lennon D, Stewart J, Trenholme A, Drinkovic D, Peat B, Taylor S, Read K, Roberts S, Voss L. Invasive Group A Streptococcal Infection and Vaccine Implications, Auckland, New Zealand. Emerg Infect Dis 2011;17:983-9. [DOI: 10.3201/eid/1706.100804] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
30 Timmis A, Parkins K, Kustos I, Riordan FA, Efstratiou A, Carrol ED. Invasive group A streptococcal infections in children presenting to a paediatric intensive care unit in the North West of England. J Infect 2010;60:183-6. [PMID: 20004215 DOI: 10.1016/j.jinf.2009.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
31 Steer JA, Lamagni T, Healy B, Morgan M, Dryden M, Rao B, Sriskandan S, George R, Efstratiou A, Baker F, Baker A, Marsden D, Murphy E, Fry C, Irvine N, Hughes R, Wade P, Cordery R, Cummins A, Oliver I, Jokinen M, Mcmenamin J, Kearney J. Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK. Journal of Infection 2012;64:1-18. [DOI: 10.1016/j.jinf.2011.11.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
32 Plainvert C, Doloy A, Loubinoux J, Lepoutre A, Collobert G, Touak G, Trieu-cuot P, Bouvet A, Poyart C. Invasive group A streptococcal infections in adults, France (2006–2010). Clinical Microbiology and Infection 2012;18:702-10. [DOI: 10.1111/j.1469-0691.2011.03624.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 7.0] [Reference Citation Analysis]
33 Olsen RJ, Shelburne SA, Musser JM. Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol 2009;11:1-12. [PMID: 18710460 DOI: 10.1111/j.1462-5822.2008.01225.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 5.9] [Reference Citation Analysis]
34 Bruun T, Rath E, Oppegaard O, Skrede S. Beta-Hemolytic Streptococci and Necrotizing Soft Tissue Infections. Adv Exp Med Biol 2020;1294:73-86. [PMID: 33079364 DOI: 10.1007/978-3-030-57616-5_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lamagni TL, Neal S, Keshishian C, Hope V, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A. Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003-2004. Clin Microbiol Infect 2008;14:1002-9. [PMID: 19040471 DOI: 10.1111/j.1469-0691.2008.02076.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
36 Saeed K, Esposito S, Gould I, Ascione T, Bassetti M, Bonnet E, Bouza E, Chan M, Davis JS, De Simone G, Dryden M, Gottlieb T, Hijazi K, Lye DC, Pagliano P, Petridou C, Righi E, Segreti J, Unal S, Yalcin AN. Hot topics in necrotising skin and soft tissue infections. International Journal of Antimicrobial Agents 2018;52:1-10. [DOI: 10.1016/j.ijantimicag.2018.02.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
37 Steer AC, Lamagni T, Curtis N, Carapetis JR. Invasive group a streptococcal disease: epidemiology, pathogenesis and management. Drugs 2012;72:1213-27. [PMID: 22686614 DOI: 10.2165/11634180-000000000-00000] [Cited by in Crossref: 116] [Cited by in F6Publishing: 91] [Article Influence: 11.6] [Reference Citation Analysis]
38 Lamagni TL, Neal S, Keshishian C, Powell D, Potz N, Pebody R, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A. Predictors of death after severe Streptococcus pyogenes infection. Emerg Infect Dis 2009;15:1304-7. [PMID: 19751599 DOI: 10.3201/eid1508.090264] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
39 Turner CE, Sommerlad M, McGregor K, Davies FJ, Pichon B, Chong DL, Farzaneh L, Holden MT, Spratt BG, Efstratiou A, Sriskandan S. Superantigenic activity of emm3 Streptococcus pyogenes is abrogated by a conserved, naturally occurring smeZ mutation. PLoS One 2012;7:e46376. [PMID: 23049698 DOI: 10.1371/journal.pone.0046376] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
40 Hamilton SM, Bayer CR, Stevens DL, Bryant AE. Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis. J Infect Dis 2014;209:1429-35. [PMID: 24218498 DOI: 10.1093/infdis/jit594] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
41 Santos MS, Ribeiro GS, Oliveira TQ, Santos RC, Gouveia E, Salgado K, Takahashi D, Fontes C, Campos LC, Reis MG, Ko AI, Reis JN. Burden of group A streptococcal meningitis in Salvador, Brazil: report of 11 years of population-based surveillance. Int J Infect Dis 2009;13:456-61. [PMID: 19019714 DOI: 10.1016/j.ijid.2008.09.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
42 Takahashi G. A Patient of Using Presepsin to Diagnose Streptococcal Toxic Shock Syndrome during Anticancer Drug Treatment. Case Rep Crit Care 2019;2019:3240501. [PMID: 31139474 DOI: 10.1155/2019/3240501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Morshedtalab Z, Rahimi G, Emami-Nejad A, Farasat A, Mohammadbeygi A, Ghaedamini N, Negahdary M. Antibacterial Assessment of Zinc Sulfide Nanoparticles against Streptococcus pyogenes and Acinetobacter baumannii. Curr Top Med Chem 2020;20:1042-55. [PMID: 32250224 DOI: 10.2174/1381612826666200406095246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Thielemans E, Oliver J, McMinn A, Baker C, Britton PN, Clark J, Marshall H, Blyth CC, Francis J, Buttery J, Smeesters PR, Crawford N, Steer AC. Clinical Description and Outcomes of Australian Children With Invasive Group A Streptococcal Disease. Pediatr Infect Dis J 2020;39:379-84. [PMID: 32091492 DOI: 10.1097/INF.0000000000002596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Lee CY, Lee YJ, Chen CC, Kuo LJ. Streptococcal toxic shock syndrome after hemorrhoidectomy: A case report. World J Clin Cases 2021; 9(33): 10238-10243 [PMID: 34904094 DOI: 10.12998/wjcc.v9.i33.10238] [Reference Citation Analysis]
46 Soriano N, Vincent P, Auger G, Cariou ME, Moullec S, Lagente V, Ygout JF, Kayal S, Faili A. Full-Length Genome Sequence of Type M/emm83 Group A Streptococcus pyogenes Strain STAB1101, Isolated from Clustered Cases in Brittany. Genome Announc 2015;3:e01459-14. [PMID: 25614568 DOI: 10.1128/genomeA.01459-14] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
47 Quaglietta L, Martinelli M, Staiano A. Serious infectious events and ibuprofen administration in pediatrics: a narrative review in the era of COVID-19 pandemic. Ital J Pediatr 2021;47:20. [PMID: 33514404 DOI: 10.1186/s13052-021-00974-0] [Reference Citation Analysis]
48 Turner CE, Kurupati P, Jones MD, Edwards RJ, Sriskandan S. Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection. J Infect Dis 2009;200:555-63. [PMID: 19591574 DOI: 10.1086/603541] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
49 Meisal R, Andreasson IK, Høiby EA, Aaberge IS, Michaelsen TE, Caugant DA. Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles. J Clin Microbiol 2010;48:842-51. [PMID: 20042624 DOI: 10.1128/JCM.01312-09] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
50 Grayson W. Infectious diseases of the skin. McKee's Pathology of the Skin. Elsevier; 2012. pp. 760-895. [DOI: 10.1016/b978-1-4160-5649-2.00018-4] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
51 Bellapianta JM, Ljungquist K, Tobin E, Uhl R. Necrotizing Fasciitis: . Journal of the American Academy of Orthopaedic Surgeons 2009;17:174-82. [DOI: 10.5435/00124635-200903000-00006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
52 Imöhl M, Reinert RR, Ocklenburg C, van der Linden M. Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. FEMS Immunol Med Microbiol 2010;58:389-96. [PMID: 20146737 DOI: 10.1111/j.1574-695X.2010.00652.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
53 Siljander T, Lyytikäinen O, Vähäkuopus S, Säilä P, Jalava J, Vuopio-Varkila J. Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland. J Clin Microbiol 2009;47:477-80. [PMID: 19073871 DOI: 10.1128/JCM.01663-08] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
54 Bryant AE, Bayer CR, Aldape MJ, Stevens DL. The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections. Curr Opin Infect Dis 2015;28:231-9. [PMID: 25918957 DOI: 10.1097/QCO.0000000000000160] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
55 Pitché P, Diata AB, Faye O, Tounkara TM, Niamba P, Mouhari-Toure A, Ly F, Soumah MM, Some-Korsaga N, Akakpo AS, Diané BF, Cissé M, Niang S, Traore A, Saka B. Risk factors associated with necrotizing fasciitis of the lower limbs: A multicenter case-control study. Ann Dermatol Venereol 2021;148:161-4. [PMID: 33558036 DOI: 10.1016/j.annder.2020.08.056] [Reference Citation Analysis]
56 Safar A, Lennon D, Stewart J, Trenholme A, Drinkovic D, Peat B, Taylor S, Read K, Roberts S, Voss L. Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand. Emerg Infect Dis 2011;17:983-9. [PMID: 21749758 DOI: 10.3201/eid/1706.100804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Mearkle R, Saavedra-Campos M, Lamagni T, Usdin M, Coelho J, Chalker V, Sriskandan S, Cordery R, Rawlings C, Balasegaram S. Household transmission of invasive group A Streptococcus infections in England: a population-based study, 2009, 2011 to 2013. Euro Surveill 2017;22:30532. [PMID: 28537550 DOI: 10.2807/1560-7917.ES.2017.22.19.30532] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
58 Nanduri SA, Onukwube J, Apostol M, Alden N, Petit S, Farley M, Harrison LH, Como-Sabetti K, Smelser C, Burzlaff K, Cieslak P, Schaffner W, Van Beneden CA. Challenges in Surveillance for Streptococcal Toxic Shock Syndrome: Active Bacterial Core Surveillance, United States, 2014-2017. Public Health Rep 2021;:333549211013460. [PMID: 33960856 DOI: 10.1177/00333549211013460] [Reference Citation Analysis]
59 Ahmed MI, Nadeem M, Bandi S. A rare case of osteomyelitis of the clavicle in a child due to Group A streptococcal infection. BMJ Case Rep 2019;12:e227090. [PMID: 30975773 DOI: 10.1136/bcr-2018-227090] [Reference Citation Analysis]
60 Pandey M, Calcutt A, Ozberk V, Chen Z, Croxen M, Powell J, Langshaw E, Mills JL, Jen FE, McCluskey J, Robson J, Tyrrell GJ, Good MF. Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice. Sci Adv 2019;5:eaax3013. [PMID: 31517054 DOI: 10.1126/sciadv.aax3013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
61 Le Turnier P, Boutoille D, Joyau C, Veyrac G, Asseray N. Bacterial infections and NSAIDs exposure? Seek septic complications. Eur J Intern Med 2017;41:e33-4. [PMID: 28302389 DOI: 10.1016/j.ejim.2017.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
62 Baroux N, D'Ortenzio E, Amédéo N, Baker C, Ali Alsuwayyid B, Dupont-Rouzeyrol M, O'Connor O, Steer A, Smeesters PR. The emm-cluster typing system for Group A Streptococcus identifies epidemiologic similarities across the Pacific region. Clin Infect Dis 2014;59:e84-92. [PMID: 24965347 DOI: 10.1093/cid/ciu490] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
63 Franklinos LH, Efstratiou A, Macgregor SK, John SK, Hopkins T, Cunningham AA, Lawson B. Streptococcus pyogenes Infection in a Free-Living European Hedgehog (Erinaceus europaeus). Ecohealth 2015;12:689-92. [PMID: 26242215 DOI: 10.1007/s10393-015-1051-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
64 Olsen RJ, Ashraf M, Gonulal VE, Ayeras AA, Cantu C, Shea PR, Carroll RK, Humbird T, Greaver JL, Swain JL, Chang E, Ragasa W, Jenkins L, Lally KP, Blasdel T, Cagle P, Musser JM. Lower respiratory tract infection in cynomolgus macaques (Macaca fascicularis) infected with group A Streptococcus. Microbial Pathogenesis 2010;49:336-47. [DOI: 10.1016/j.micpath.2010.06.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
65 Metzgar D, Baynes D, Hansen CJ, McDonough EA, Cabrera DR, Ellorin MM, Blair PJ, Russell KL, Faix DJ. Inference of antibiotic resistance and virulence among diverse group A Streptococcus strains using emm sequencing and multilocus genotyping methods. PLoS One 2009;4:e6897. [PMID: 19730733 DOI: 10.1371/journal.pone.0006897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
66 Adalat S, Dawson T, Hackett SJ, Clark JE; In association with the British Paediatric Surveillance Unit. Toxic shock syndrome surveillance in UK children. Archives of Disease in Childhood 2014;99:1078-82. [DOI: 10.1136/archdischild-2013-304741] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
67 Hamilton SM, Bayer CR, Stevens DL, Lieber RL, Bryant AE. Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. J Infect Dis 2008;198:1692-8. [PMID: 18939933 DOI: 10.1086/593016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
68 Sharma H, Ong MR, Ready D, Coelho J, Groves N, Chalker V, Warren S. Real-time whole genome sequencing to control a Streptococcus pyogenes outbreak at a national orthopaedic hospital. J Hosp Infect 2019;103:21-6. [PMID: 31283948 DOI: 10.1016/j.jhin.2019.07.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
69 Coelho JM, Platt S, Efstratiou A. Evaluation of sclB gene variation in Streptococcus pyogenes (Lancefield group A Streptococcus) and potential for subtyping. Journal of Medical Microbiology 2012;61:615-21. [DOI: 10.1099/jmm.0.040535-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Mylvaganam H, Bruun T, Vindenes HA, Langeland N, Skrede S. Molecular epidemiological investigation of an outbreak of invasive beta-haemolytic streptococcal infection in western Norway. Clin Microbiol Infect 2009;15:245-52. [PMID: 19178544 DOI: 10.1111/j.1469-0691.2008.02664.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
71 Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjänen J. Predictors of mortality in beta-hemolytic streptococcal bacteremia: a population-based study. J Infect 2009;58:266-72. [PMID: 19261333 DOI: 10.1016/j.jinf.2009.01.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
72 Hope VD, Marongiu A, Parry JV, Ncube F. The extent of injection site infection in injecting drug users: findings from a national surveillance study. Epidemiol Infect 2010;138:1510-8. [DOI: 10.1017/s0950268810000324] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
73 Caillet-Gossot S, Rousset-Rouviere C, Arlaud K, Dubus JC, Bosdure E. [Clustered cases of intrafamily invasive Streptococcus pyogenes infection (or group A streptococcus)]. Arch Pediatr 2011;18:1305-9. [PMID: 22056211 DOI: 10.1016/j.arcped.2011.09.031] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Stockmann C, Ampofo K, Hersh AL, Blaschke AJ, Kendall BA, Korgenski K, Daly J, Hill HR, Byington CL, Pavia AT. Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010. Clin Infect Dis 2012;55:479-87. [PMID: 22534148 DOI: 10.1093/cid/cis422] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
75 Bryant AE, Aldape MJ, Bayer CR, Katahira EJ, Bond L, Nicora CD, Fillmore TL, Clauss TR, Metz TO, Webb-Robertson BJ, Stevens DL. Effects of delayed NSAID administration after experimental eccentric contraction injury - A cellular and proteomics study. PLoS One 2017;12:e0172486. [PMID: 28245256 DOI: 10.1371/journal.pone.0172486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
76 Green AE, Rowlands RS, Cooper RA, Maddocks SE. The effect of the flavonol morin on adhesion and aggregation of Streptococcus pyogenes. FEMS Microbiol Lett 2012;333:54-8. [PMID: 22591139 DOI: 10.1111/j.1574-6968.2012.02598.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
77 Parks T, Barrett L, Jones N. Invasive streptococcal disease: a review for clinicians. Br Med Bull 2015;115:77-89. [PMID: 26209784 DOI: 10.1093/bmb/ldv027] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 6.1] [Reference Citation Analysis]
78 Chen KY, Cheung M, Burgner DP, Curtis N. Toxic shock syndrome in Australian children. Arch Dis Child 2016;101:736-40. [PMID: 27117838 DOI: 10.1136/archdischild-2015-310121] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
79 Lepoutre A, Doloy A, Bidet P, Leblond A, Perrocheau A, Bingen E, Trieu-Cuot P, Bouvet A, Poyart C, Lévy-Bruhl D; Microbiologists of the Epibac Network. Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol 2011;49:4094-100. [PMID: 21976764 DOI: 10.1128/JCM.00070-11] [Cited by in Crossref: 70] [Cited by in F6Publishing: 21] [Article Influence: 6.4] [Reference Citation Analysis]
80 Tan LK, Eccersley LR, Sriskandan S. Current views of haemolytic streptococcal pathogenesis. Curr Opin Infect Dis 2014;27:155-64. [PMID: 24573012 DOI: 10.1097/QCO.0000000000000047] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
81 Soltani AM, Best MJ, Francis CS, Allan BJ, Askari M, Panthaki ZJ. Trends in the Incidence and Treatment of Necrotizing Soft Tissue Infections: An Analysis of the National Hospital Discharge Survey. Journal of Burn Care & Research 2014. [DOI: 10.1097/bcr.0000000000000010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
82 Middleton B, Morris P, Carapetis J. Invasive group A streptococcal infection in the Northern Territory, Australia: Case report and review of the literature: Invasive group A streptococcal infection. J Paediatr Child Health 2014;50:869-73. [DOI: 10.1111/jpc.12659] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
83 Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalén C, Jasir A; Strep-EURO Study Group. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008;46:2359-67. [PMID: 18463210 DOI: 10.1128/JCM.00422-08] [Cited by in Crossref: 257] [Cited by in F6Publishing: 75] [Article Influence: 18.4] [Reference Citation Analysis]
84 Dickson C, Pham MT, Nguyen V, Brubacher C, Silverman MS, Khaled K, Hovhannisyan G. Community outbreak of invasive group A streptococcus infection in Ontario, Canada. Can Commun Dis Rep 2018;44:182-8. [PMID: 31011300 DOI: 10.14745/ccdr.v44i78a06] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
85 Brown CN, Pollard TC, Iyer S, Andrade AJ. Invasive group A streptococcal infection: an update on the epidemiology and orthopaedic management. J Bone Joint Surg Br 2010;92:763-9. [PMID: 20513870 DOI: 10.1302/0301-620X.92B6.23447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]